Previous Article | Next Article ![]()
J Bacteriol, February 1998, p. 527-537, Vol. 180, No. 3
Department of Biology, Georgia State
University, Atlanta, Georgia 30303
Received 26 September 1997/Accepted 1 December 1997
We have identified and characterized the protease-resistant SecA
fragments (X. Chen, H. Xu, and P. C. Tai, J. Biol. Chem. 271:29698-29706, 1996) through immunodetection with region-specific antibodies, chemical extraction, and sequencing analysis. The 66-, 36-, and 27-kDa proteolytic fragments in the membranes all start at
Met1, whereas the 48-kDa fragment starts at
Glu361. The overlapping of the sequences of the 66- and
48-kDa fragments indicates that they are derived from different SecA
molecules. These two fragments were generated differently in response
to ATP hydrolysis and protein translocation. Furthermore, the presence
of membrane is required for the generation of the 48-kDa fragment but
not for that of the 66-kDa fragment. These data suggest that there are
two different integral forms of SecA in the membrane: SecAS and SecAM. The combination of these two forms of SecA has
several membrane-interacting domains. Both forms of SecA are integrated in the membrane, since both the 48- and 66-kDa fragments could be
derived from urea- or Na2CO3-washed membranes.
Moreover, all fragments are resistant to extraction with a high
concentration of salt or with heparin, but the membrane-specific 48-kDa
SecA domain is more sensitive to Na2CO3 or urea
extraction. This suggests that this domain may interact with other
membrane proteins in an aqueous microenvironment and therefore may form
a part of the protein-conducting channel.
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification and Characterization of
Protease-Resistant SecA Fragments: SecA Has Two Membrane-Integral
Forms
and
*
Corresponding author. Mailing address: Biology
Department, Georgia State University, 24 Peachtree Center Ave., Kell
Hall 402, Atlanta, GA 30303. Phone: (404) 651-3109. Fax: (404)
651-2509. E-mail: biopct{at}panther.gsu.edu.
Present address: Regeneron Pharmaceutical Inc., Tarrytown, NY
10591.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |